This is a coherent explanation of ANAVEX 2-73 and the current trial... http://www.anavex.com/?post_type=news&p=1165
"The first part is a scheduled Phase 1b/2a trial of approximately 40 patients who will receive either ANAVEX 2-73 or standard of care (donepezil) with ANAVEX 2-73. The study will explore dose and schedule as well as the efficacy of the combination. Patients in this study will have the option to rollover into a single open-label study in order to further accumulate safety, tolerability and efficacy data.
The second part of the study is designed as a double-blind Phase 2 trial and will randomize AD patients to standard of care (donepezil) or standard of care (donepezil) with ANAVEX 2-73 with a primary outcome measure at 26 weeks efficacy based on standard cognitive measures. All patients from this second study will also have the option to rollover into the single open-label study in order to further accumulate safety, tolerability and efficacy data."
And here's an article about the novel measurement technique being used (anybody else scared for Anavex?) http://alzheimersnewstoday.com/2014...th-neuronetrix-for-alzheimers-clinical-trial/
I hope it goes well for Anavex (more accurately for AD sufferers), but it is clearly very early in what we know to be a long process.
- Forums
- ASX - By Stock
- Longs - SP and Bashers with multiple userids
This is a coherent explanation of ANAVEX 2-73 and the current...
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $1.447K | 368K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 52624257 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 127090587 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 52624257 | 0.003 |
60 | 89908098 | 0.002 |
27 | 122861099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 127090587 | 26 |
0.005 | 32268732 | 28 |
0.006 | 13948927 | 18 |
0.007 | 47851651 | 23 |
0.008 | 22758132 | 24 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |